Zhihe Computing
Series A in 2024
Zhihe Computing is an artificial intelligence and intelligent computing company that specializes in the design and development of high-performance, scalable central processing units (CPUs) and RISC-V processors. The company focuses on creating integrated circuit chips that prioritize energy efficiency and offer optimal solutions for various applications. In addition to chip design, Zhihe Computing provides integrated circuit sales and information system integration services, ensuring that its products and services effectively meet the diverse needs of its clients.
Yuce Biotechnology
Series B in 2024
Yuce Biotechnology is a high-tech company focused on the industrialization of single-molecule immunodiagnostic technologies.
Shengyin Optoelectronics
Series A in 2023
Shengyin Optoelectronics is a micro-nano manufacturing company specializing in the development of ornamental films for electrical appliances and portable electronics. The firm focuses on advancing the optoelectronics sector through innovative technologies such as nano-imprinting, micro-injection molding, micro-electroforming, and nano-printing. These techniques enable the creation of microstructures with exceptional resolution, reaching as fine as 30 nanometers on large substrate surfaces. Shengyin Optoelectronics provides equipment and solutions for various industries, including consumer electronics, new energy vehicles, solar energy, and biomedical applications, effectively serving the growing demands of these sectors.
Beijing Witinmem Technology Co., Ltd., founded in October 2017, specializes in artificial intelligence chips and system solutions utilizing processing-in-memory technology in NOR Flash memory. The company's innovative technology enables the execution of deep neural network inference directly within the NOR Flash memory, which significantly enhances performance, power efficiency, and accuracy. Witinmem's solutions are particularly applicable in speech and image processing, positioning the company at the forefront of low-cost, low-power AI chip development. By facilitating local AI processing independent of cloud resources, Witinmem is dedicated to advancing the integration of AI into everyday smart devices. The company is headquartered in Beijing, China.
Sanyou Bio
Series B in 2022
Sanyou Biopharmaceuticals Co., Ltd. is a contract research organization based in Shanghai, China, specializing in the research and development of innovative antibody drugs. Founded in 2015, the company offers a comprehensive range of services, including raw material preparation, lead antibody production, candidate optimization, therapeutic screening, and the establishment of animal models and cell lines. Sanyou has developed and validated over 20 core technological platforms that enhance antibody drug discovery and development, such as antibody engineering and drug efficacy evaluation. The company's state-of-the-art research facility in Caohejing Hi-Tech Park supports its mission to provide advanced drug development solutions, ultimately aiming to improve treatment outcomes for patients.
Jingkun Technology is a pioneering manufacturer in China, specializing in cloud-based development platforms aimed at enhancing business automation. The company offers an innovative Enterprise IT ERP System that emphasizes automated data governance and workflow management. By integrating automation, low-code development, and advanced data analytics, Jingkun facilitates streamlined orchestration of business processes across multiple systems. Its platform caters to both citizen developers and professional users, enabling them to monitor data and automate workflows efficiently. By leveraging these capabilities, Jingkun Technology seeks to redefine digital orchestration and eliminate information silos, positioning itself as a leader in the automation sector.
Beijing Witinmem Technology Co., Ltd., founded in October 2017, specializes in artificial intelligence chips and system solutions utilizing processing-in-memory technology in NOR Flash memory. The company's innovative technology enables the execution of deep neural network inference directly within the NOR Flash memory, which significantly enhances performance, power efficiency, and accuracy. Witinmem's solutions are particularly applicable in speech and image processing, positioning the company at the forefront of low-cost, low-power AI chip development. By facilitating local AI processing independent of cloud resources, Witinmem is dedicated to advancing the integration of AI into everyday smart devices. The company is headquartered in Beijing, China.
Sanyou Bio
Series B in 2021
Sanyou Biopharmaceuticals Co., Ltd. is a contract research organization based in Shanghai, China, specializing in the research and development of innovative antibody drugs. Founded in 2015, the company offers a comprehensive range of services, including raw material preparation, lead antibody production, candidate optimization, therapeutic screening, and the establishment of animal models and cell lines. Sanyou has developed and validated over 20 core technological platforms that enhance antibody drug discovery and development, such as antibody engineering and drug efficacy evaluation. The company's state-of-the-art research facility in Caohejing Hi-Tech Park supports its mission to provide advanced drug development solutions, ultimately aiming to improve treatment outcomes for patients.
Innovative Cellular Therapeutics
Series C in 2019
Innovative Cellular Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, that specializes in the research and development of cell therapy. Established in 2009, the company focuses on creating chimeric antigen receptor T (CAR-T) products aimed at treating both blood cancers and solid tumors. Its development program includes innovative approaches such as allogeneic CAR-T therapies using gene editing and gene therapy techniques. Innovative Cellular Therapeutics is dedicated to advancing cellular immunotherapies that target late-stage solid tumors, including colorectal and thyroid cancers, with the goal of improving patient outcomes and supporting healthier lives.
Honor Alliance
Series B in 2019
Beijing Honor Alliance Technology Development Co., Ltd, established in 2009, specializes in information technology consulting and technical support services. The company offers a range of solutions including IT operation management, business continuity management consulting, disaster recovery system construction, and risk and emergency management services. Additionally, it provides training for business continuity management authority certification and conducts audit certification. With a presence in multiple cities across China, including Shanghai, Chengdu, Shenzhen, Wuhan, Nanjing, and Zhengzhou, Honor Alliance is positioned to support various enterprises in enhancing their IT capabilities and resilience.
HyperAI Cloud
Angel Round in 2019
HyperAI Cloud Technology (Beijing) Co., Ltd. is a high-tech enterprise established in 2017, specializing in artificial intelligence cloud computing technology. Based in Beijing, the company focuses on the development and application of solutions that enhance industry model algorithm optimization, parallel computing architecture, and cloud computing service delivery. HyperAI Cloud provides a comprehensive range of services, including product demand analysis and advanced cloud technology architecture. The company caters to various sectors by offering a one-stop application service solution for AI, encompassing training and reasoning capabilities for computer vision, speech recognition, and natural language processing. HyperAI Cloud is supported by a skilled entrepreneurial team, with core members drawn from prominent firms such as Shuguang, Baidu, Tencent, EMC, and VMware.